Focus on HIV Care

Back to articles

Pre-exposure prophylaxis with tenofovir-based regimens is likely safe during pregnancy and lactation

KEY POINT

In a large systematic review of pregnant or lactating women who are HIV infected and those who are not, use of tenofovir disoproxil fumarate (Viread—Gilead) did not result in adverse outcomes in fetuses or infants exposed to the drug, compared with use of non-tenofovir based regimens.